The Australian examines development of low-cost water purifiers by Indian companies

The Australian reports on how four large businesses in India are developing low-cost water purifiers for some of the country's "poorest of the poor."

"Not only is it good business - India's water purifier market is worth an estimated [U.S. $335 million] a year and growing by 20 percent annually - but it offers huge social and economic benefits," the newspaper writes, noting the global threat of water-borne diseases, such as cholera, diarrhea and typhoid. According to the WHO, 2.2 million children die annually from a lack of safe water and sanitation, and "[i]n India alone, about 400,000 children die annually from diseases spread by contaminated water," the newspaper writes.

"The challenge for business is to create a suitable product at the right price. In India, for example, many rural inhabitants have no access to power or running water, meaning that any low-cost water purifier must be able to operate in the most basic environment," the newspaper notes.

The article details how companies are working on products that use "ultra violet (UV) filtration, the more expensive reverse osmosis process, and chemical filtration." The piece also includes comments by Maria Neira, WHO Director of Public Health and Environment and leaders at two of the four companies working to develop low-cost water filters, who speak of the economic impact of clean water and sanitation (Hiscock, 8/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Artemisinin resistance detected in children with severe malaria in Uganda